Effect of Perilesional Injections of PEG-Interleukin-2 on Basal Cell Carcinoma

Abstract

The therapeutic response induced by perilesional PEG-IL-2 injections was found to be an encouraging, safe, and well-tolerated treatment of BCC. Further studies including a larger patient population and long-term follow-up are necessary in order to substantiate these findings.